Literature DB >> 22673325

Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor.

Chao Li1, Xian Xuan Chi, Wenrui Xie, J A Strong, J-M Zhang, G D Nicol.   

Abstract

Previously we demonstrated that sphingosine 1-phosphate receptor 1 (S1PR(1)) played a prominent, but not exclusive, role in enhancing the excitability of small-diameter sensory neurons, suggesting that other S1PRs can modulate neuronal excitability. To examine the potential role of S1PR(2) in regulating neuronal excitability we used the established selective antagonist of S1PR(2), JTE-013. Here we report that exposure to JTE-013 alone produced a significant increase in excitability in a time- and concentration-dependent manner in 70-80% of recorded neurons. Internal perfusion of sensory neurons with guanosine 5'-O-(2-thiodiphosphate) (GDP-β-S) via the recording pipette inhibited the sensitization produced by JTE-013 as well as prostaglandin E(2). Pretreatment with pertussis toxin or the selective S1PR(1) antagonist W146 blocked the sensitization produced by JTE-013. These results indicate that JTE-013 might act as an agonist at other G protein-coupled receptors. In neurons that were sensitized by JTE-013, single-cell RT-PCR studies demonstrated that these neurons did not express the mRNA for S1PR(2). In behavioral studies, injection of JTE-013 into the rat's hindpaw produced a significant increase in the mechanical sensitivity in the ipsilateral, but not contralateral, paw. Injection of JTE-013 did not affect the withdrawal latency to thermal stimulation. Thus JTE-013 augments neuronal excitability independently of S1PR(2) by unknown mechanisms that may involve activation of other G protein-coupled receptors such as S1PR(1). Clearly, further studies are warranted to establish the causal nature of this increased sensitivity, and future studies of neuronal function using JTE-013 should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673325      PMCID: PMC3544961          DOI: 10.1152/jn.00825.2011

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  62 in total

1.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

Review 2.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

Authors:  Dagmar Meyer zu Heringdorf; Karl H Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-10-04

3.  Deafness and stria vascularis defects in S1P2 receptor-null mice.

Authors:  Mari Kono; Inna A Belyantseva; Athanasia Skoura; Gregory I Frolenkov; Matthew F Starost; Jennifer L Dreier; Darcy Lidington; Steffen-Sebastian Bolz; Thomas B Friedman; Timothy Hla; Richard L Proia
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

4.  Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist.

Authors:  Makoto Osada; Yutaka Yatomi; Tsukasa Ohmori; Hitoshi Ikeda; Yukio Ozaki
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

5.  Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia.

Authors:  Amol M Patwardhan; Phoebe E Scotland; Armen N Akopian; Kenneth M Hargreaves
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

6.  Inflammatory pain: the cellular basis of heat hyperalgesia.

Authors:  Jiehong Huang; Xuming Zhang; Peter A McNaughton
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 7.  FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.

Authors:  Volker Brinkmann
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

8.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

9.  Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia.

Authors:  Yoshihito Kanai; Tomokazu Hara; Aki Imai; Ayano Sakakibara
Journal:  J Pharm Pharmacol       Date:  2007-05       Impact factor: 3.765

10.  Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology?

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Front Pharmacol       Date:  2011-05-31       Impact factor: 5.810

View more
  7 in total

1.  A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression.

Authors:  Xuyi Yue; Hongjun Jin; Hui Liu; Adam J Rosenberg; Robyn S Klein; Zhude Tu
Journal:  Org Biomol Chem       Date:  2015-06-25       Impact factor: 3.876

2.  Epac activation sensitizes rat sensory neurons through activation of Ras.

Authors:  Behzad Shariati; Eric L Thompson; Grant D Nicol; Michael R Vasko
Journal:  Mol Cell Neurosci       Date:  2015-11-18       Impact factor: 4.314

3.  Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2.

Authors:  Zonghua Luo; Qianwa Liang; Hui Liu; Joshi Sumit; Hao Jiang; Robyn S Klein; Zhude Tu
Journal:  Nucl Med Biol       Date:  2020-07-27       Impact factor: 2.408

4.  Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.

Authors:  Chao Li; Jun-nan Li; Joanne Kays; Miguel Guerrero; Grant D Nicol
Journal:  J Neuroinflammation       Date:  2015-04-12       Impact factor: 8.322

5.  The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism.

Authors:  Melissa R Pitman; Alexander C Lewis; Lorena T Davies; Paul A B Moretti; Dovile Anderson; Darren J Creek; Jason A Powell; Stuart M Pitson
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 6.  Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Authors:  Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

Review 7.  Chemical and genetic tools to explore S1P biology.

Authors:  Stuart M Cahalan
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.